SCHEDULED REGULAR ENDOSCOPIC INTERVENTIONS FOR PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS IMPROVE TRANSPLANT- -FREE SURVIVAL

被引：0

作者：

Oezdirik, Burcin ^{[1
]}

机构：

[1] Charite, Hepatol & Gastroenterol, Berlin, Germany

来源：

HEPATOLOGY | 2022年 / 76卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

4702

引用

下载

页码：S1463 / S1464

页数：2

共 50 条

[21] Experience With Endoscopic Therapy in Patients With Primary Sclerosing Cholangitis
Al-Lehibi, Abed H.
Kumar, Nitin
Ammar, Tarek
Murad, Faris
Mullady, Daniel
Early, Dayna S.
Azar, Riad R.
Edmundowicz, Steven A.
Jonnalagadda, Sreenivasa S.
GASTROINTESTINAL ENDOSCOPY, 2010, 71 (05) : AB312 - AB312
[22] Survival Outcomes of Liver Transplant Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Disease
Mousa, Omar Y.
Patel, Neej J.
Pang, Maoyin
Nimri, Sarah M.
Harnois, Denise
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S511 - S512
[23] Enhanced liver fibrosis score predicts transplant-free survival in primary sclerosing cholangitis
Vesterhus, Mette
Hov, Johannes Roksund
Holm, Anders
Schrumpf, Erik
Nygard, Stale
Godang, Kristin
Andersen, Ina Marie
Naess, Sigrid
Thorburn, Douglas
Saffioti, Francesca
Vatn, Morten
Gilja, Odd Helge
Lund-Johansen, Fridtjof
Syversveen, Trygve
Brabrand, Knut
Pares, Albert
Ponsioen, Cyriel Y.
Pinzani, Massimo
Farkkila, Martti
Moum, Bjorn
Ueland, Thor
Rosjo, Helge
Rosenberg, William
Boberg, Kirsten Muri
Karlsen, Tom H.
HEPATOLOGY, 2015, 62 (01) : 188 - 197
[24] Biliary microbial patterns in primary sclerosing cholangitis are linked to poorer transplant-free survival
Oezdirik, Burcin
Scherf, Maria
Brumercek, Ana
Nicklaus, Jule M. M.
Kruis, Tassilo
Haber, Philipp K. K.
Pratschke, Johann
Tacke, Frank
Sigal, Michael
HEPATOLOGY COMMUNICATIONS, 2023, 7 (06)
[25] Imaging-based diagnosis of sarcopenia for transplant-free survival in primary sclerosing cholangitis
Keshoofi, Pedram
Schindler, Philipp
Rennebaum, Florian
Cordes, Friederike
Morgul, Haluk
Wildgruber, Moritz
Heinzow, Hauke S.
Pascher, Andreas
Schmidt, Hartmut H.
Huesing-Kabar, Anna
Praktiknjo, Michael
Trebicka, Jonel
Seifert, Leon Louis
BMC GASTROENTEROLOGY, 2024, 24 (01)
[26] Risk of endoscopic biliary interventions in primary sclerosing cholangitis is similar between patients with and without cirrhosis
Peiseler, Moritz
Reiners, David
Pinnschmidt, Hans O.
Sebode, Marcial
Jung, Franziska
Hartl, Johannes
Zenouzi, Roman
Ehlken, Hanno
Groth, Stefan
Schachschal, Guido
Roesch, Thomas
Weiler-Normann, Christina
Lohse, Ansgar W.
Schramm, Christoph
PLOS ONE, 2018, 13 (08):
[27] ENDOTROPHIN (PRO-C6) IS INCREASED IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS AND PREDICTIVE OF TRANSPLANT-FREE SURVIVAL
Zepeda, Joseph Benjamin
Yazdanfar, Maryam
Dean, Richard
Liu, Chung-Heng
Dhaliwal, Sandeep
Ebert, Christina
Luo, Yi
Zhao, Lei
Bowlus, Christopher L.
HEPATOLOGY, 2022, 76 : S1503 - S1504
[28] VITAMIN D SUPPLEMENTATION IS ASSOCIATED WITH LIVER TRANSPLANT-FREE AND HEPATOBILIARY MALIGNANCY-FREE SURVIVAL IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS
Mulligan, Connor
Pratt, Henry
Mitsialis, Vanessa
Pratt, Daniel S.
HEPATOLOGY, 2021, 74 : 788A - 789A
[29] PREDICTIVE VALUE OF FIB-4 INDEX FOR TRANSPLANT-FREE SURVIVAL IN PRIMARY SCLEROSING CHOLANGITIS
Matsumoto, Kosuke
Tanaka, Atsushi
Arizumi, Toshihiko
Tazuma, Susumu
Nakazawa, Takahiro
Isayama, Hiroyuki
Tsuyuguchi, Toshio
Takikawa, Hajime
HEPATOLOGY, 2019, 70 : 773A - 774A
[30] Do endoscopic interventions make a difference in primary sclerosing cholangitis? Clinical and endoscopic outcomes.
Enns, R
Eloubeidi, M
Mergener, K
Jowell, PS
Branch, MS
Baillie, J
GASTROINTESTINAL ENDOSCOPY, 1998, 47 (04) : AB48 - AB48

← 1 2 3 4 5 →